The Genetic Characterization of Dementia
2 other identifiers
observational
87
1 country
1
Brief Summary
Background: \- Researchers are interested in learning more about dementia and its causes. They want to look at the genetic basis of dementia. Identifying genetic aspects of dementia may help provide better tests and treatments for it. It may also show rare gene variants that can cause or alter a person's risks for developing dementia. This study will look at people who have dementia, their family members, and healthy volunteers. Objectives: \- To study genetic influences on dementia. Eligibility:
- Individuals who have been diagnosed with dementia.
- Family members of individuals who have been diagnosed with dementia.
- Healthy volunteers at least 18 years of age. Design:
- Participants will be interviewed and answer questions about their medical history. They will also provide general information on the relatives' medical histories.
- Participants will provide a blood sample for genetic testing.
- Participants will remain on the study for up to 10 years. They will have regular visits to monitor their brain health and function.
- Treatment will not be provided as part of this study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2003
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 14, 2003
CompletedFirst Submitted
Initial submission to the registry
May 29, 2013
CompletedFirst Posted
Study publicly available on registry
June 4, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 20, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
September 20, 2016
CompletedApril 5, 2018
September 20, 2016
13.5 years
May 29, 2013
April 4, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Genetic cause of disease identified
Once every 12-24 months
Eligibility Criteria
You may qualify if:
- Previous diagnosis of Dementia by neurologist, other medical care provider, or researcher accompanied by sufficient clinical and/or laboratory evidence
- Clinical confirmation of Dementia by the investigator and his associates either by exam and/or review of medical records
- Family member of diagnosed dementia patient
- Healthy controls
You may not qualify if:
- Individuals with any movement disorder secondary to a specific environmental exposure, birth injury, metabolic disorder, or brain infection such as encephalitis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institute of Aging, Clinical Research Unit
Baltimore, Maryland, 21224, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andrew Singleton, Ph.D.
National Institute on Aging (NIA)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- OTHER
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 29, 2013
First Posted
June 4, 2013
Study Start
March 14, 2003
Primary Completion
September 20, 2016
Study Completion
September 20, 2016
Last Updated
April 5, 2018
Record last verified: 2016-09-20